RVMD Sep 2024 26.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Acceptable
Key Insights Revolution Medicines will host its Annual General Meeting on 20th of June Total pay for CEO Mark Goldsmith...
- GlobeNewswire
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be a featured speaker in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference. Details of the company’s participation are as follows: Goldman Sachs 45th Annual Gl
- GuruFocus.com
Revolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...
Insights into RVMD's Financial Health and Future Directions
© 2024 Yahoo. All rights reserved.